Antireflux Transoral Incisionless Fundoplication Using EsophyX: 12‐Month Results of a Prospective Multicenter Study

2008157 citationsJournal Articlehybrid Open Access

Authors

Guy‐Bernard Cadière · Centre Hospitalier Universitaire de Saint-Pierre

Michel Buset · Centre Hospitalier Universitaire de Saint-Pierre

Vinciane Muls · Centre Hospitalier Universitaire de Saint-Pierre

Amin Rajan · Centre Hospitalier Interrégional Edith Cavell

Thomas Rösch · Charité - Universitätsmedizin Berlin

Alexander J. Eckardt · Charité - Universitätsmedizin Berlin

J Weerts

Abstract

The 12-month results showed that EsophyX-TIF was safe and effective in improving quality of life and for reducing symptoms, PPI use, hiatal hernia, and esophagitis, as well as increasing the LES resting pressure and normalizing esophageal pH and cardia circumference in chronic GERD patients.

Topics & Keywords

Gastroesophageal reflux and treatments Esophageal and GI Pathology Dysphagia Assessment and Management

Publication Details

Published in: World Journal of Surgery

Volume 32, Issue 8, pp. 1676-1688

DOI: 10.1007/s00268-008-9594-9

Field-Weighted Citation Impact: 10.53

Command Palette

Antireflux Transoral Incisionless Fundoplication Using EsophyX: 12‐Month Results of a Prospective Multicenter Study

Authors

Abstract

Topics & Keywords

Publication Details